Gastrointestinal (GI) Stool Testing Market Forecast to Reach USD 1.24 Billion by 2031, Supported by Screening Expansion and Molecular Test Adoption

Mordor Intelligence has published a new report on the gastrointestinal (GI) stool testing market, offering a comprehensive analysis of trends, growth drivers, and future projections.
Gastrointestinal (GI) Stool Testing Market Analysis

According to Mordor Intelligence, the gastrointestinal (GI) stool testing market size [https://www.mordorintelligence.com/industry-reports/gi-stool-testing-market?utm_source=abnewswire] is estimated at USD 0.89 billion in 2026 and is expected to reach USD 1.24 billion by 2031, reflecting consistent expansion during the forecast period. This growth outlook highlights how stool-based diagnostics are becoming a routine part of disease screening, infection detection, and gastrointestinal disorder monitoring.

As diagnostic workflows move toward efficiency and patient convenience, the gastrointestinal (GI) stool testing industry is witnessing higher test volumes through home collection kits, rapid immunochemical assays, and multiplex molecular panels. These shifts are improving access while supporting long-term market growth across both developed and emerging regions.

Gastrointestinal (GI) Stool Testing Market Trends Shaping Demand

Rising prevalence of GI disorders and colorectal cancer screening mandates Increased screening eligibility and guideline updates are enlarging the population undergoing stool-based tests.

Surge in point-of-care immunochemical (FIT/iFOBT) test adoption Rapid, same-visit tests that remove dietary restrictions are gaining ground, especially in clinics and outpatient settings.

Expansion of molecular enteric pathogen panels Multiplex PCR platforms that detect multiple pathogens in one run are increasingly adopted in hospitals and labs.

Growth of at-home collection and telehealth integration Home sample kits, combined with remote healthcare services, support broader test access and convenience.

Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/ja/industry-reports/gi-stool-testing-market?utm_source=abnewswire

Gastrointestinal (GI) Stool Testing Market Segmentation

*
By Product Type

*
Instruments

*
Consumables

*
By Test Type

*
Occult Blood

*
Ova & Parasites

*
Bacterial Pathogens

*
Viral Pathogens

*
Others

*
By Technology

*
Immunoassay

*
Molecular PCR

*
Next-Generation Sequencing

*
Lateral Flow / Rapid Tests

*
By End User

*
Hospitals

*
Diagnostic Labs

*
Physician Offices & POC Sites

*
Others

*
By Geography

*
North America

*
United States

*
Canada

*
Mexico

*
Europe

*
Germany

*
United Kingdom

*
France

*
Italy

*
Spain

*
Rest of Europe

*
Asia-Pacific

*
China

*
Japan

*
India

*
Australia

*
South Korea

*
Rest of Asia-Pacific

*
Middle East and Africa

*
GCC

*
South Africa

*
Rest of Middle East and Africa

*
South America

*
Brazil

*
Argentina

*
Rest of South America

Gastrointestinal (GI) Stool Testing Market Key Players

The gastrointestinal (GI) stool testing market features established diagnostics companies with broad portfolios and global reach. These players focus on strengthening their market share through test menu expansion, workflow efficiency, and regulatory compliance.

Key participants include:

*
Abbott Laboratories

*
Genova Diagnostics

*
bioMerieux SA

*
Cardinal Health

*
Danaher Corporation (Beckman Coulter, Inc.)

Gastrointestinal (GI) Stool Testing Market Conclusion

The gastrointestinal (GI) stool testing market is positioned for steady and sustainable expansion as healthcare systems emphasize early detection, preventive screening, and patient-friendly diagnostics. Rising awareness of gastrointestinal disorders and broader acceptance of stool-based testing are strengthening long-term market growth.

As healthcare providers seek reliable, non-invasive diagnostic tools, the gastrointestinal (GI) stool testing industry is expected to maintain its role as a core component of modern diagnostic pathways. Balanced growth across market size, share, and application areas underscores the importance of stool testing in future gastrointestinal care strategies.

Industry Related Reports:

At-Home Peptic Ulcer Testing Market:This market covers urea breath test kits, stool antigen home kits, and finger-stick serology kits, distributed through online direct-to-consumer platforms, retail pharmacies, and telehealth partnerships across major global regions.

Get more insights: https://www.mordorintelligence.com/industry-reports/at-home-peptic-ulcer-testing-market?utm_source=abnewswire

Inflammatory Bowel Disease (IBD) Diagnostic Market Size:The global IBD diagnostic market is valued at USD 4.03 billion in 2025 and is projected to reach USD 4.85 billion by 2030, growing at a CAGR of 3.78% during the forecast period.

Get more insights: https://www.mordorintelligence.com/industry-reports/inflammatory-bowel-disease-diagnostics-market?utm_source=abnewswire

Escherichia Coli Testing Market Share: The Escherichia coli testing market is estimated at USD 2.56 billion in 2026 and is forecast to reach USD 3.51 billion by 2031, expanding at a CAGR of 6.55%, driven by clinical and environmental testing demand.

Get more insights: https://www.mordorintelligence.com/industry-reports/escherichia-coli-testing-market?utm_source=abnewswire

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com https://www.mordorintelligence.com/

Media Contact
Company Name: Mordor Intelligence Private Limited
Contact Person: Jignesh Thakkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=gastrointestinal-gi-stool-testing-market-forecast-to-reach-usd-124-billion-by-2031-supported-by-screening-expansion-and-molecular-test-adoption]
Phone: +1 617-765-2493
Address:11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli
City: Hyderabad
State: Telangana 500008
Country: India
Website: https://www.mordorintelligence.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.